In a report released today, Jason Celino from KeyBanc maintained a Buy rating on PTC (PTC – Research Report). The company’s shares ...

PTC Inc. ( (PTC) ) has released its Q4 earnings. Here is a breakdown of the information PTC Inc. presented to its investors. PTC Inc. is a ...

Nov 13 (Reuters) - The U.S. Food and Drug Administration approved PTC Therapeutics' (PTCT.O), opens new tab gene ... new ...

The biopharmaceutical company posted revenue of $196.8 million in the period, also beating Street forecasts. Five analysts surveyed by Zacks expected $173.5 million. PTC Therapeutics expects full-year ...

Tampa Bay forecasters say it’s too early to tell where the storm will go, but urged residents to keep an eye on forecasts.

Fiscal '25 Constant Currency ARR Growth Guidance: 9% to 10%. PTC Inc (NASDAQ:PTC) reported a solid 25% year-over-year growth in free cash flow for fiscal 2024. The company achieved a 12% year-over ...

Good afternoon, ladies and gentlemen, and thank you for standing by, and welcome to today's PTC 2024 fourth quarter conference call. During this presen ...

Good afternoon, ladies and gentlemen, and thank you for standing by, and welcome to today's PTC 2024 fourth-quarter conference call. (Operator Instructions) I would now like to turn the call over ...

As one would expect for a gracefully aging institution, the aesthetic of Willamette Week has evolved over the ...

Copyright © 2024 MarketWatch, Inc. All rights reserved.